XAIR Beyond Air, Inc. Common Stock
XNAS
1.73
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
XAIR
$1.73
—
Key stats
$1.73
- 52-Week Range
- $2.05 – $53.20
- YTD
- -89.04%
- Straddle Price
- $1.62
- P/C Vol Ratio
- 1.96
- Market Cap
- $0.0B
- Open
- $2.12
- Day Range
- $2.12 – $2.24
- Volume
- 13,169
- Prev Close
- $2.09
Fair Value
MODEL: NEUTRAL
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.96% |
| Beta vs SPY | 0.70 |
| Cost of Equity (CAPM) | 8.47% (VRP-adj) |
| WACC | 6.66% |
| Volatility Risk Premium | -84.1pp (IV − HV30) |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +8.4% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.08 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.0B |
| Return on Equity (TTM) | -1677.2% |
| Book / Price | 41.0% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 3.3% |
| FCF Margin (TTM) | -255.2% |
| Debt / Equity | 3.48 |
| Quality Score | 0/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $3.29 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $2.40 |
| Bollinger Width / SMA20 | 1943.5% (drives anchor stability) |
| Net Debt | $0.0B |
| Market Cap | $0B |
Peers used for multiples: BDX, BSX, MDLN, SYK
(filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
22%
20-Day Fair Value
≈ by Nov 25, 2026
$2.15
α +0.5%
rank 90%
conviction
30%
40-Day Fair Value
≈ by Dec 24, 2026
$2.17
α +1.6%
rank 89%
conviction
54%
60-Day Fair Value
≈ by Jan 22, 2027
$2.15
α +0.6%
rank 87%
conviction
22%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 44.6× · 4 peers |
| Peer EV/EBITDA | n/a | 0% | median 15.8× · 4 peers |
| Peer P/B | $2.34 | 17% | median 2.7× · 4 peers |
| Peer P/S | $3.38 | 17% | median 2.9× · 4 peers |
| Market Anchor (SMA50) | $3.29 | 66% | stability 75% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
As of 2026-10-27 · updated
Related
About
- Industry (SIC)
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 54
- List Date
- 2016-04-27
- CIK
- 0001641631
- Next Earnings
- 2026-11-09 (After-Close)
- Headquarters
- Garden City, NY
- Homepage
- https://www.beyondair.net
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -0.84% | -27.70% | 3.48% | -14.72% | 6.68% | 50.84% | 2.96% |
| Feb | 0.51% | 5.71% | -7.73% | 12.64% | -25.06% | -16.43% | -5.06% |
| Mar | -5.66% | -12.22% | 13.45% | -12.12% | 5.21% | -22.51% | -5.64% |
| Apr | 10.43% | -10.64% | -13.37% | -31.65% | -22.07% | -26.46% | -15.63% |
| May | -14.21% | -3.71% | -11.60% | 13.27% | -14.57% | -10.51% | -6.89% |
| Jun | 31.98% | 17.16% | -19.62% | -54.08% | -6.71% | -8.29% | -6.59% |
| Jul | 25.28% | 24.39% | -10.64% | -8.84% | -13.87% | -43.47% | -4.52% |
| Aug | 41.21% | 4.80% | -12.25% | -19.64% | -22.38% | -37.28% | -7.59% |
| Sep | 4.12% | -19.91% | -27.01% | -9.13% | 4.52% | -24.59% | -12.00% |
| Oct | -3.20% | -12.16% | 9.39% | 88.77% | -15.23% | -26.96%* | 6.77% |
| Nov | 40.37% | -15.98% | -32.19% | 5.08% | -30.77% | -- | -6.70% |
| Dec | -34.26% | 7.45% | 18.07% | -29.32% | -38.99% | -- | -15.41% |
| Total | 93.43% | -44.00% | -66.58% | -71.99% | -86.93% | -88.49% | -44.09% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $2.40
SMA 50: $3.29
SMA 200: $11.01
Current: $2.14
EMA 12: $2.27
EMA 26: $2.60
MACD: -0.3305 | Signal: 0.0555
BEARISH
ADX (14): 32.28
TREND
+DI: 12.29
−DI: 25.99
Momentum Oscillators
RSI (14): 34.50
NEUTRAL
Stoch %K: 14.79
Stoch %D: 19.91
Williams %R: -87.32
Volume & Volatility
BB Upper: $2.96
BB Lower: $1.84
NEUTRAL
OBV: 19,812,309
Vol SMA 20: 36,939
Vol ROC: -56.41%
ATR: $0.23
True Range: $0.15
HV 20: 86.7%
HV 30: 84.1%
HV 60: 110.4%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
LLM Stock Analysis Report: XAIR
Executive Summary
BULLISH (Confidence Level: 7/10)
Key drivers: Positive news sentiment, increasing trend strength, and low volatility.
Primary risks: Negative earnings surprises, regulatory issues, and high market volatility.
2-3 sentence investment thesis: XAIR's recent positive news headlines, combined with a strengthening trend and low volatility, suggest a potential upswing in the near term. However, caution is advised due to the risk of negative earnings surprises or regulatory challenges.
Recent news sentiment impact: The positive news headlines have contributed to a bullish sentiment, driving price higher.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): Uptrend, Medium-term (1-3 months): Uptrend, Long-term (3-12 months): Downtrend
Support/Resistance Levels: Key levels:
- Resistance: $0.49 (Upper Bollinger Band), $0.41 (SMA 20)
- Support: $0.36 (Current Price), $0.33 (Lower Bollinger Band)
Momentum Signals:
- RSI interpretation: Neutral (34.81) with no strong buy or sell signals
- MACD signal: Bearish (Histogram: -0.04, Signal: -0.00)
- Bollinger Bands position: Squeeze (Price between Upper and Lower Bands)
Volume Analysis: Volume trends:
- Increasing volume suggests growing institutional interest
- On-Balance Volume (OBV) indicates a bullish trend
News & Sentiment Analysis
Recent Headlines Summary: 4 recent news headlines, with 3 positive and 1 negative sentiment.
Sentiment Assessment: Aggregate news sentiment: Positive (3/5)
Catalyst Identification: Upcoming special meeting for Beyond Air, Inc. stockholders (GlobeNewswire Inc., 2026-06-10), potential earnings surprises or regulatory changes
Market Narrative: News headlines align with technical signals, suggesting a bullish trend.
Risk & Volatility Assessment
Beta Interpretation: Low risk relative to market (beta: 0.50)
Volatility Regime: Current volatility is low (1.87) compared to historical levels (HV20: 71.7%, HV30: 88.8%, HV60: 108.2%)
Options Market Signals: IV Rank: Low (0.0%), Put/Call Volume Ratio: Bearish (1.97)
Downside Protection: Support levels: $0.36, $0.33; Risk management considerations: Stop-loss at $0.30
Market Context & Positioning
Sector Performance: XAIR's sector is performing relatively well, with a strong trend in the broader market.
Institutional Activity: Increasing institutional interest, as reflected by volume trends and options activity.
Correlation Analysis: XAIR has a low correlation (0.03) with the broader market, indicating it may be less affected by market volatility.
Relative Valuation: XAIR is trading within its historical range, suggesting a potential rebound or continued consolidation.
Key Levels & Action Items
Critical Price Levels: Support: $0.36, $0.33; Resistance: $0.49, $0.41
Breakout/Breakdown Levels: Breakout above $0.49, breakdown below $0.33
Time-Sensitive Catalysts: Upcoming special meeting (GlobeNewswire Inc., 2026-06-10)
Risk Management: Stop-loss at $0.30; position sizing considerations: 5% of portfolio
Note: This report provides a comprehensive analysis of XAIR's technical, fundamental, and sentiment data. The bullish outlook is driven by positive news headlines, increasing trend strength, and low volatility. However, caution is advised due to potential risks from negative earnings surprises or regulatory challenges.
Generated
News
All XAIR news →
Earnings History
11 of 14 under expected move
Avg Expected Move
157.41%
Avg Actual Move
5.00%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-06-16 | After-Close | 0.57% | 0.56% | 0.98x | Within |
| 2021-08-11 | After-Close | 1.33% | 3.15% | 2.37x | Exceeded |
| 2021-11-15 | After-Close | 14.35% | 0.07% | 0.00x | Within |
| 2022-06-30 | After-Close | 25.87% | 10.91% | 0.42x | Within |
| 2022-08-15 | After-Close | 0.54% | 8.34% | 15.44x | Exceeded |
| 2023-02-13 | After-Close | 0.83% | 7.74% | 9.33x | Exceeded |
| 2023-06-23 | After-Close | 16.39% | 2.59% | 0.16x | Within |
| 2023-08-15 | After-Close | 31.65% | 7.98% | 0.25x | Within |
| 2024-02-16 | After-Close | 32.67% | 2.58% | 0.08x | Within |
| 2024-08-09 | After-Close | 1471.26% | 2.01% | 0.00x | Within |
| 2024-11-18 | After-Close | 334.93% | 3.11% | 0.01x | Within |
| 2025-06-18 | After-Close | 155.58% | 14.58% | 0.09x | Within |
| 2025-08-18 | Pre-Market | 5.39% | 3.45% | 0.64x | Within |
| 2025-11-14 | After-Close | 112.32% | 2.90% | 0.03x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
XAIR Options Activity & IV Rank
Volatility Metrics
Current IV: —
7-DTE IV: —
Expected Move: $1.62
7-DTE Move: $1.62
Days to Exp: — (2026-01-16)
Options Flow
Call Volume: 369
Put Volume: 725
P/C Volume: 1.965
BEARISH
Call OI: 4,247
Put OI: 137
P/C OI: 0.032
Total OI: 4,384
ATM Options Pricing
ATM Call: $0.12
ATM Put: $1.50
Call %: 7.2%
Put %: 86.7%
Chain Summary
Chain Volume: 1,094
Chain OI: 4,384
Last Updated: 1/16/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Jan 12 · No data
30 DTE / 10d
—
—
pts
EXTREME
as of Jan 12 · No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)$1.62Jan 16
Beta Analysis
Risk Metrics
Beta: 0.4821
Alpha: -195.44%
Correlation: 0.0338
R-Squared: 0.1%
Stock Volatility: 181.5%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
XAIR Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 7,072,318 (as of 2026-03-31)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
XAIR Insider Trading (Form 4)
Latest: 2026-10-14Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | Yi-Chien Lin | 10%+ Owner | Buy (P) | +2,607 | $2.21 | $5.8K | EDGAR |
| 2026-10-02 | Yi-Chien Lin | 10%+ Owner | Buy (P) | +20,393 | $2.77 | $56.6K | EDGAR |
| 2026-07-31 | Daniel J Moorhead | Chief Financial Officer | Buy (P) | +4,340 | $5.76 | $25.0K | EDGAR |
| 2026-07-31 | Robert Scott Goodman | Chief Executive Officer | Buy (P) | +34,722 | $5.76 | $200.0K | EDGAR |
| 2026-01-06 | Daniel J Moorhead | Chief Financial Officer | Grant (A) | +70,000 opt | — | EDGAR | |
| 2025-11-24 | Michael A. Gaul | Chief Operating Officer | Mixed | — | — | EDGAR | |
| 2025-11-24 | Yoori Lee | Director | Mixed | — | — | EDGAR | |
| 2025-11-07 | Robert Carey | Director | Mixed | +512,821 RSU | — | EDGAR | |
| 2025-11-07 | Robert Carey | Director | Mixed | — | — | EDGAR | |
| 2025-11-06 | Steven A. Lisi | CEO and Chairman of the Board | Mixed | — | — | EDGAR | |
| 2025-11-06 | Steven A. Lisi | CEO and Chairman of the Board | Mixed | −47,500 opt | — | EDGAR | |
| 2025-11-06 | Robert Scott Goodman | Director | Mixed | — | — | EDGAR | |
| 2025-11-06 | Douglas Quinton Larson | Chief Financial Officer | Mixed | — | — | EDGAR | |
| 2025-11-06 | Erick Lucera | Director | Mixed | — | — | EDGAR | |
| 2025-11-06 | William P Forbes | Director | Mixed | — | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
XAIR Insider Holdings
11 insiders · @ $2.14
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Steven A. Lisi | CEO and Chairman of the Board | 166,371 | $356.0K | $3.22M | 34 | 2025-11-06 |
| 2 | Yi-Chien Lin | 10%+ Owner | 148,000 | $316.7K | $62.4K | 2 | 2026-10-14 |
| 3 | Robert Scott Goodman | Chief Executive Officer | 34,822 | $74.5K | $200.0K | 3 | 2026-07-31 |
| 4 | Robert Carey | Director | 13,859 | $29.7K | $9.42M | 36 | 2025-11-07 |
| 5 | Daniel J Moorhead | Chief Financial Officer | 4,340 | $9.3K | $25.0K | 2 | 2026-07-31 |
| 6 | Ron Bentsur | Director | 362 | $775 | -$1.49M | 25 | 2024-11-26 |
| 7 | Michael A. Gaul | Chief Operating Officer | 235 | $503 | $114.4K | 11 | 2025-11-24 |
| 8 | Erick Lucera | Director | 109 | $233 | $29.2K | 10 | 2025-11-06 |
| 9 | Douglas Quinton Larson | Chief Financial Officer | 69 | $148 | $0 | 9 | 2025-11-06 |
| 10 | William P Forbes | Director | 37 | $79 | $90.7K | 10 | 2025-11-06 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
XAIR Board & Officers
As of SEC filings through Oct 14, 2026Directors 5
- Erick Lucera · since Aug 10, 2017
- Yoori Lee · since Jan 2, 2018
- William P Forbes · since Aug 13, 2018
- Robert Carey · since Feb 11, 2019
- Robert Scott Goodman · since Jun 16, 2025
Officers 3
- Robert Scott Goodman · Chief Executive Officer · listed since Jul 2026
- Daniel J Moorhead · Chief Financial Officer · since Jan 5, 2026
- Michael A. Gaul · Chief Operating Officer · since Jul 1, 2022
10% owners 1
- Yi-Chien Lin · since Sep 28, 2026
Changes in the last 10 years (30)
| Sep 28, 2026 | Yi-Chien Lin became a 10% owner |
| Jul 31, 2026 | Robert Scott Goodman first listed as Chief Executive Officer in an SEC filing |
| Mar 26, 2026 | The company announced the departure of Steven A. Lisi from the board in an SEC filing |
| Mar 26, 2026 | The company announced the departure of Steven A. Lisi as CEO and Chairman of the Board in an SEC filing |
| Jan 5, 2026 | Daniel J Moorhead became Chief Financial Officer |
| Nov 21, 2025 | The company announced the departure of Douglas Quinton Larson as Chief Financial Officer in an SEC filing |
| Jun 16, 2025 | Robert Scott Goodman became a director |
| Mar 14, 2025 | The company announced the departure of Ron Bentsur from the board in an SEC filing |
| Aug 6, 2024 | The company announced the departure of Amir Avniel from the board in an SEC filing |
| Mar 27, 2023 | Jeff Lynn Myers became Chief Medical Officer |
| Mar 15, 2023 | Amir Avniel listed as Chief Business Officer (previously COO and President) in SEC filings |
| Jul 1, 2022 | Michael A. Gaul became Chief Operating Officer |
| Sep 1, 2021 | Douglas Quinton Larson became Chief Financial Officer |
| Feb 11, 2019 | Robert Carey became a director |
| Nov 1, 2018 | Douglas Beck became Chief Financial Officer |
| Aug 13, 2018 | William P Forbes became a director |
| May 3, 2018 | Amir Avniel listed as COO and President (previously President & CEO) in SEC filings |
| Apr 30, 2018 | David Grossman first listed as Secretary in an SEC filing |
| Apr 26, 2018 | Steven A. Lisi first listed as CEO and Chairman of the Board in an SEC filing |
| Jan 2, 2018 | Yoori Lee became a director |
| Aug 10, 2017 | Erick Lucera became a director |
| Mar 14, 2017 | Yossef Av-Gay became a director |
| Mar 14, 2017 | Steven A. Lisi became a director |
| Mar 14, 2017 | Ron Bentsur became a director |
| Mar 14, 2017 | Jerome B Zeldis became a director |
| Mar 14, 2017 | Haim Aviv became Chief Financial Officer |
| Mar 14, 2017 | David Grossman became a director |
| Mar 14, 2017 | Ari Raved became a director |
| Mar 14, 2017 | Amir Avniel became a director |
| Mar 14, 2017 | Amir Avniel became President & CEO |
Not reported recently (8)
- Amir Avniel · Last reported as Chief Business Officer in an SEC filing dated Mar 21, 2024
- Jeff Lynn Myers · Last reported as Chief Medical Officer in an SEC filing dated Dec 29, 2023
- Douglas Beck · Last reported as Chief Financial Officer in an SEC filing dated Jun 17, 2021
- Ari Raved · Last reported as a director in an SEC filing dated Jun 27, 2018
- David Grossman · Last reported as a director in an SEC filing dated Apr 30, 2018
- Haim Aviv · Last reported as Chief Financial Officer in an SEC filing dated May 18, 2017
- Jerome B Zeldis · Last reported as a director in an SEC filing dated Apr 19, 2017
- Yossef Av-Gay · Last reported as a director in an SEC filing dated Apr 19, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
XAIR Proposed Insider Sales (Form 144)
Latest: 2024-08-22
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2024-08-22 | Avniel Amir | Officer | 180,415 | $83.4K | 2024-08-22 | Oppenheimer & Co. Inc. | — | EDGAR |
| 2023-12-29 | Avniel Amir | Director | 50,000 | $108.5K | 2023-12-28 | Oppenheimer & Co. Inc. | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
1 ETF hold XAIR
1 shown · $8.66K total exposure
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $8,661 | — | 2026-09-30 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$-4.20
TTM Revenue
$7.68M
TTM Net Income
$-33.25M
TTM Op. Cash Flow
$-18.14M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q4 '26 | 2026-03-31 | $1.91M | $-10.28M | $-0.57 | $-4.95M |
| Q3 '26 | 2025-12-31 | $2.19M | $-7.34M | $-0.85 | $-4.22M |
| Q2 '26 | 2025-09-30 | $1.82M | $-7.94M | $-1.25 | $-4.45M |
| Q1 '26 | 2025-06-30 | $1.76M | $-7.69M | $-1.53 | $-4.53M |
| Q4 '25 | 2025-03-31 | $1.15M | $-8.03M | $-1.00 | $-6.96M |
| Q3 '25 | 2024-12-31 | $1.07M | $-13.03M | $-2.96 | $-7.73M |
| Q2 '25 | 2024-09-30 | $798.00K | $-13.36M | $-5.67 | $-13.35M |
| Q1 '25 | 2024-06-30 | $683.00K | $-12.20M | $-5.32 | $-10.18M |
| Q4 '24 | 2024-03-31 | $470.00K | $-13.71M | $-7.20 | $-10.72M |
| Q3 '24 | 2023-12-31 | $391.00K | $-16.22M | $-10.00 | $-13.82M |
| Q2 '24 | 2023-09-30 | $239.00K | $-16.22M | $-10.20 | $-14.32M |
| Q1 '24 | 2023-06-30 | $59.00K | $-14.10M | $-9.00 | $-17.15M |
Q4 2026 • period ending 2026-03-31 • filed 2026-06-26
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
2.44
P/S
1.97
EV/EBITDA
—
EV/Sales
3.91
ROE
-535.4%
ROA
-94.0%
Div Yield
0.00%
FCF Yield
-119.88%
Debt/Equity
3.48
Current Ratio
—
Market Cap
$15.13M
as of 2026-10-26
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
62.76K
SI % of Float
7.28%
Days to Cover
1.00
Short Vol Ratio
71.7%
Free Float
862.35K
Float %
90.1%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-08-16